Details of the Drug
General Information of Drug (ID: DMGLSPC)
Drug Name |
Salicylhydroxamic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Salicylhydroxamic acid; N,2-Dihydroxybenzamide; 89-73-6; 2-Hydroxybenzohydroxamic acid; Salicylohydroxamic acid; SHAM; Salicylohydroximic acid; Benzamide, N,2-dihydroxy-; 2-Hydroxybenzhydroxamic acid; O-Hydroxybenzohydroxamic acid; SalicylhydroxaMicacid; SHA; 2,N-Dihydroxy-benzamide; NSC 5088; NSC 193440; Saliaylhydroxamic acid; UNII-8Q07182D0T; 2-hydroxybenzenecarbohydroxamic acid; Salicylic Hydroxamic Acid; EINECS 201-934-3; Salicylhydroxamic acid, 99%; MLS000069410; CHEMBL309339; CHEBI:45615; NSC5088
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 153.14 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Combinatorial Drugs (CBD) | Click to Jump to the Detailed CBD Information of This Drug | ||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||